A developability assessment at an early stage can provide a better understanding of candidates, deliver better and safer therapeutic candidates and reduce risk during late-stage development.
TORONTO (PRWEB)
September 29, 2022
Biological macromolecules (monoclonal antibodies, recombinant proteins, fusion proteins, antibody-drug-conjugates, polypeptides and vaccines, etc.) are powerful therapeutics, and their characterization has drawn considerable attention and urgency in the biopharmaceutical industry. A developability assessment at an early stage can provide a better understanding of candidates, deliver better and safer therapeutic candidates and reduce risk during late-stage development.
In this webinar, the featured speakers will review: Antibody quality attributes that are critical to development and traditional and state-of-the-art analytical methods to monitor those attributes; A practical workflow for developability assessment, including in silico evaluation, extended characterization and preliminary stability studies using appropriate analytical methods; And case studies on conducting developability assessment experiments.
This webinar reviews the methodologies that are used to characterize important attributes of biopharmaceutical proteins. The speakers will discuss relevant analytical methods, including techniques (SPR, BLI, DSC, DLS, CD, LC-MS/MS, etc.) to determine thermal stability, activity, protein sequence, post-translational modifications, degradation, glycosylation, folding, disulfide bond shuffling and aggregation. An aberrant result for these attributes may raise quality issues.
Register for this webinar to get technical insight into analytical technologies in biophysical and mass spectrometry characterization as well as affinity analysis for biological macromolecules.
Join experts from ChemPartner Biologics, Jinghan Su, Assistant Director, Head of Developability; and Qian Sun, PhD, Director, Head of Analytical Development and Quality Control, for the live webinar on Wednesday, October 19, 2022, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Biological Macromolecules: Exploring Analytical Development and QC Case Studies in Antibody Developability and Biologics CMC.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Share article on social media or email: